🇺🇸 FDA
Patent

US 11174469

Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders

granted A61KA61K48/00A61K9/127

Quick answer

US patent 11174469 (Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders) held by CRISPR THERAPEUTICS AG expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CRISPR THERAPEUTICS AG
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K48/00, A61K9/127, A61K9/14